Keeping you up to date on recent developments in orthopedics, including: Younger knee replacement patients more likely to require reoperation; New research predicts whether rheumatoid arthritis patients will respond to treatment; Steroid inhalers/pills for asthma linked to heightened risk of brittle bones and fractures.
Keeping you up to date on recent developments in orthopedics, including: Magnetic field and hydrogels could be used to grow new cartilage; COVID-19 pandemic has dramatic impact on osteoporosis management, finds new global study; Casting call: Why immobilizing helps in healing; Osteoarthritis biomarker could help 300 million people worldwide.
Keeping you up to date on recent developments in orthopedics, including: Light stimulation makes bones heavier; NCCN: New research finds low bone health testing rates after prostate cancer treatment; A diet high in prunes prevents bone loss associated with spinal cord injuries.
PARIS – Bonetag SAS, of Perpignan, France, is developing a universal medical device designed to ensure in vivo traceability for orthopedic knee replacements.
The COVID-19 pandemic has been a bump in the road for developers of digital surgical systems that include robotics, but the technology is still in demand. That was the message from industry leaders at the Advanced Medical Technology Association’s Virtual Medtech Conference.
Keeping you up to date on recent developments in orthopedics, including: LED-based UV irradiation safely prevents the loss of bone and muscle mass in mice; Coupling antibiotics with stem cells to fight off bone infections; Study: Unnecessary stress testing performed prior to knee and hip replacement surgeries.
Keeping you up to date on recent developments in orthopedics, including: SCS reduces pain and motor symptoms in PD patients; Is rheumatoid arthritis two different diseases?; Lockdown impact: Worsening symptoms for people with bone, joint and muscle pain.
Smith+Nephew plc has signed a definitive agreement to acquire the Extremity Orthopedics business of Integra Lifesciences Holdings Corp. for $240 million in cash. The deal, which is slated to close around the end of this year, gives the London-based company a catalog of devices, implants and instruments that generated $90 million in revenue in 2019.
Keeping you up to date on recent developments in oncology, including: New nanoparticle could overcome aggregation-caused quenching for cancer treatment; Epigenetic resistance to PARP inhibitors; Statins help pancreatic tumors go from bad to worse; Sit up straight: PBT coming to a chair near you.
Keeping you up to date on recent developments in orthopedics, including: Technology for printing customized neuroprostheses on a 3D bioprinter; AI could expand healing with bioscaffolds; AI detects osteoarthritis years before it develops; 'Bandage' developed to rebuild broken bone.
RSS
